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Introduction
The significant burden of metabolic syndrome (MS) -a cluster of cardiovascular risk factors consisting of abdominal obesity, elevated blood pressure, elevated plasma glucose, and atherogenic dyslipidaemia -in the general population, as far as the strong association between MS and cardiovascular disease (CVD), give serious implications for health professionals in the field of cardiac rehabilitation (CR); understandably, MS deserves increased clinical attention as an associated comorbidity at the entry of rehabilitation programs, being patients qualified for a diagnosis of MS frequently candidates to more aggressive approach to management of cardiovascular risk factors. Conversely, physicians working in the CR setting often fail to recognize the importance to diagnose MS in patients with coronary artery disease (CAD) and peripheral arterial obstructive disease (PAOD), this being likely due to the sparse body of evidence in this subgroup of patients: despite the large availability of communitybased studies, little evidence still exists on the prevalence of MS in patients referred for CR, as far as about their cardiovascular fate. Moreover, several agencies have stressed lifestyle intervention -weight reduction, anti-atherogenic diet, increased physical activity, and smoking cessation -as one way to consistently cut into the cardiovascular risk of patients with MS [1] , but unfortunately a comprehensive strategy for appropriate management has not been definitely validated and offered as a guideline for CR health operators. Regarding dietary intervention, a growing body of research was originated in the field of obesity, hence focusing just on weight reduction and not encompassing all impaired components of the MS; the clustering of risk factors as a syndrome (and not simply the metabolic com- Results: MS accounted for 26% of all patients, with the highest prevalence (31%) among those admitted after acute coronary syndromes. All four dietary regimens were significantly more prescribed (p< 0.001) among patients with MS as compared to controls, with low sodium (95%) and low fat (90%) diets as the most represented patterns. All patients with MS were prescribed multiple dietary patterns, with adoption of a comprehensive low energy, low fat, and lowplications of obesity) reasonably allows to differentiate a structured diet for obesity from an hypothetical structured diet for MS. To begin to address these issues, we performed this study with the aim to provide estimates of the prevalence of MS in a representative CR unit and the global need for structured dietary intervention in these patients, as well as specific diet patterns targeted on the single core components of the MS.
Methods

Study design
In this observational study, a sample of patients referred to a cardiac rehabilitation facility in Northern Italy with a documented diagnosis of CAD or PAOD was tested for the presence of MS at admission. The sample was obtained at different times during the years 2004/2005, based on the availability of clinical information needed for the diagnosis of MS and documentation of nutritional evaluation. Only in-hospital patients were considered.
Diagnosis of metabolic syndrome
The clinical identification of metabolic syndrome was performed according to 2005-revised NCEP guidelines [1] . Patients were classified as having metabolic syndrome when three or more of the following risk factors were present: waist circumference >102 cm and 88 cm in men and women respectively, triglycerides ≥150 mg/dL, high-density lipoprotein cholesterol (HDL-C) <40 mg/dL and 50 mg/dL in men and women respectively, blood pressure ≥130/≥85 mmHg, and fasting glucose ≥100 mg/dL.
Dietary intervention
At the entry of the CR program, a balanced dietary program was appropriately designed by a dietitian in all patients. Current medical conditions targeting specific dietary modifications included obesity, dyslipidaemia, diabetes mellitus, and hypertension. Other modifications regarding certain nutrients (such as vitamin and mineral supplements) were assessed on individual basis. For the purposes of the study, dietary programmes were categorized into four main areas of intervention (weight control, lipid control, glycaemic control, and blood pressure control; table 1) according to medical needs shown by the single patient. However, the four dietary patterns were part of a comprehensive lifestyle modification, and shared several healthy food choices, such as the recommendation of maintaining an adequate intake of vegetables, fruits, and whole grains, as well as limiting alcohol consumption. The overall structure of the nutritional intervention also comprised delivering of intensive nutrition education by means of individual consultation at baseline and on demand, weekly group sessions, and provision of detailed written information. 
Results
The study population consisted of 209 patients (males 75%, mean age 65±8 yrs.) with the following reason for admission in the rehabilitation facility: silent ischemia in 23 patients (11%), chronic stable angina in 58 (28%), acute coronary syndrome in 87 (41%), and peripheral arterial disease stage II according to Fontaine's classification in 41 (20%). In 156 (75%) cases a recent coronary or peripheral revascularization was performed. The reason for attending the CR program was a first manifestation of CVD among 80% of total cases.
Globally, the MS was diagnosed in 55 (26%) patients, with the following prevalence of the core components of the syndrome: increased waist circumference 22%, elevated triglycerides 18%, decreased HDL-Cholesterol 44%, elevated blood pressure 62%, and increased fasting glucose 24%. The prevalence of MS was highest (31%) among patients admitted after acute coronary syndromes as compared to other cardiovascular conditions considered ( figure 1) .
The need for all single dietary patterns (figure 2) was significantly higher (p< 0.001) in patients with MS as compared to controls, with low sodium (95%) and low fat (90%) diets as the most represented patterns. Focusing on low fat, low calories, and low glucose diets (i.e. the more structured dietary interventions), a proportion of 34.3% of the total amount of diets delivered was prescribed to patients with MS ( figure 3 ); of these, 28.7% was prescribed to patients with indication to two coexisting dietary patterns, and 5.6% to patients in whom all three dietary patterns were indicated. Among patients with MS, the prescription of a low energy diet against obesity always needed to be integrated by other dietary patterns, with low sodium, low fat, and low glucose diets accounting for 92%, 87%, and 37% of cases respectively.
Discussion
In this report, we address two questions: the presence of MS among different subgroups of patients at the entry of CR programs, and the magnitude of the effort aimed at ensuring an appropriate medical nutrition therapy.
Based on our data, the MS is a frequent coexisting comorbidity among patients attending CR programs. We are aware of only two publications [2, 3] specifically addressing the presence of MS in the CR setting, both derived from studies performed in the U.S.A., and reporting a cumulative prevalence of about 50-60%. Of particular note, the study by Savage et al. [3] provided evidence for considering MS as closely associated to the whole population of patients referred to CR, rather than a condition confined to selected manifestations of CVD. These findings could be interpreted as an argument for actively searching the presence of MS when evaluating the global cardiovascular risk of our patients.
Nutritional counselling is considered of greatest importance for successful secondary prevention programmes. Since the increased emphasis on the high prevalence of MS in the population referred to CR services, we focused on dietary needs of these patients and found that, despite the overlap between MS and obesity, a more integrated dietary approach should be advocated rather than just controlling body weight. It could also be noted that these patients are often de novo prescribed nutritional therapy (as confirmed by the high proportion of first CVD manifestation in our sample), and consequently the opportunity to significantly reduce the risk of future events by means of intensive lifestyle modification should not be missed.
Based on current evidence, the exciting question as to whether a specific diet for patients with MS could be identified is likely to remain unsolved. An elegant review by Baxter et al in 2006 [4] found only three large studies on dietary patterns and the MS. Data from population-based cross-sectional studies showed that dietary patterns high in fruit and vegetables were associated with reduced prevalence of MS, as well as a diet high in fish; conversely, a significant relationship between protein from animal sources and MS was found, while plant proteins showed no association; finally, diets with a high intake of cereals and dairy foods gave inconclusive results. Among cereal-based foods, minimally processed cereal foods -in contrast to processed cereals -showed a lower risk of insulin resistance and obesity, while the hypothesis that a selected dairy food intake could give protection against MS required further confirmation. Regarding fat intake, data from the multicenter KAN-WU study [5] on 162 healthy subjects revealed that decreasing saturated fatty acid and increasing monounsaturated fatty acid might improve insulin sensitivity without effect on insulin secretion; however, authors stated that the beneficial effect of monounsaturated fat disappeared when total fat intake exceeded 38% of total energy [6] . Taken together, these findings suggest that diet composition could affect insulin resistance -the dominant pathophysiological pattern of MS -and could be harmonized in a structured dietary program to be investigated by controlled clinical trials.
In conclusion, our study highlighted the elevated cardiometabolic risk carried out by a large proportion of patients attending CR programs, as well as the need for a structured cardiometabolic-protective eating pattern, driven by all core components of MS displayed by the single patient. 
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